3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
33
Phase 3
11
Phase NA
7
Phase 1
5
Phase 4
2
Phase 2/3
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Wrist Fractures
1
Triple Negative Breast Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Portal Vein Tumor Thrombus
1
Meningiomas of the Middle Cranial Fossa
1
Hand Injuries
1
Edema
1
Dupuytren Contracture
1
Disease
1
Adenocarcinoma Of Esophagus
1
Interventions
Pemetrexed
10
Cisplatin
9
Erlotinib Hydrochloride
8
Carboplatin
7
icotinib
5
Gefitinib
5
Docetaxel
5
endostar protein
3
Zoledronic Acid
3
Radiotherapy
3
Paclitaxel
3
Gemcitabine
3
Endostatins
3
Afatinib
3
tislelizumab
2
pembrolizumab
2
osimertinib
2
lorlatinib
2
flurbiprofen axetil
2
dexamethasone 21-phosphate
2
atezolizumab
2
Vinorelbine
2
Surgical Procedures, Operative
2
Saline Solution
2
Nivolumab
2
Drug Therapy
2
Dexamethasone
2
Chemoradiotherapy
2
trametinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Non-Small-Cell Lung
×
Surgical Procedures, Operative
×
Clear all
NCT06908070
2025-04-03
CROWD
Amsterdam UMC, location VUmc
Phase 4
Recruiting
38 enrolled
NCT06357598
2024-04-10
PILOT
The Affiliated Hospital of Qingdao University
Phase 4
Unknown
30 enrolled